Literature DB >> 9430221

Human diversity in killer cell inhibitory receptor genes.

M Uhrberg1, N M Valiante, B P Shum, H G Shilling, K Lienert-Weidenbach, B Corliss, D Tyan, L L Lanier, P Parham.   

Abstract

The presence and expression of killer inhibitory receptor (KIR) and CD94:NKG2 genes from 68 donors were analyzed using molecular typing techniques. The genes encoding CD94:NKG2 receptors were present in each person, but KIR gene possession varied. Most individuals expressed inhibitory KIR for the three well-defined HLA-B and -C ligands, but noninhibitory KIR genes were more variable. Twenty different KIR phenotypes were defined. Two groups of KIR haplotypes were distinguished and occurred at relatively even frequency. Group A KIR haplotypes consist of six genes: the main inhibitory KIR, one noninhibitory KIR, and a structurally divergent KIR. Allelic polymorphism within five KIR genes was detected. Group B comprises more noninhibitory KIR genes and contains at least one additional gene not represented in group A. The KIR locus therefore appears to be polygenic and polymorphic within the human population.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9430221     DOI: 10.1016/s1074-7613(00)80394-5

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  316 in total

1.  Killer cell immunoglobulin-like receptors (KIR) typing by DNA sequencing.

Authors:  Lihua Hou; Minghua Chen; Noriko Steiner; Kanthi Kariyawasam; Jennifer Ng; Carolyn K Hurley
Journal:  Methods Mol Biol       Date:  2012

2.  Killer immunoglobulin-like receptor expression on single cells: a cautionary note.

Authors:  Britta Radeloff; Katja Laun; Maja Zirra; Armin Volz
Journal:  Immunology       Date:  2003-12       Impact factor: 7.397

3.  Complex expression of natural killer receptor genes in single natural killer cells.

Authors:  Zaheed Husain; Chester A Alper; Edmond J Yunis; Devendra P Dubey
Journal:  Immunology       Date:  2002-07       Impact factor: 7.397

Review 4.  Targeted immunotherapy for acute myeloid leukemia.

Authors:  Sumithira Vasu; Michael A Caligiuri
Journal:  Best Pract Res Clin Haematol       Date:  2011-11-11       Impact factor: 3.020

Review 5.  Natural killer cells and their receptors in multiple sclerosis.

Authors:  Gurman Kaur; John Trowsdale; Lars Fugger
Journal:  Brain       Date:  2012-06-25       Impact factor: 13.501

Review 6.  Innate immune control of HIV.

Authors:  Mary Carrington; Galit Alter
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

Review 7.  The tortoise and the hare: slowly evolving T-cell responses take hastily evolving KIR.

Authors:  Jeroen van Bergen; Frits Koning
Journal:  Immunology       Date:  2010-08-17       Impact factor: 7.397

8.  NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs.

Authors:  Vivien Béziat; Lisa L Liu; Jenny-Ann Malmberg; Martin A Ivarsson; Ebba Sohlberg; Andreas T Björklund; Christelle Retière; Eva Sverremark-Ekström; James Traherne; Per Ljungman; Marie Schaffer; David A Price; John Trowsdale; Jakob Michaëlsson; Hans-Gustaf Ljunggren; Karl-Johan Malmberg
Journal:  Blood       Date:  2013-01-16       Impact factor: 22.113

9.  Different Selected Mechanisms Attenuated the Inhibitory Interaction of KIR2DL1 with C2+ HLA-C in Two Indigenous Human Populations in Southern Africa.

Authors:  Neda Nemat-Gorgani; Hugo G Hilton; Brenna M Henn; Meng Lin; Christopher R Gignoux; Justin W Myrick; Cedric J Werely; Julie M Granka; Marlo Möller; Eileen G Hoal; Makoto Yawata; Nobuyo Yawata; Lies Boelen; Becca Asquith; Peter Parham; Paul J Norman
Journal:  J Immunol       Date:  2018-03-16       Impact factor: 5.422

Review 10.  Cell mediators of autoimmune hepatitis and their therapeutic implications.

Authors:  Aldo J Montano-Loza; Albert J Czaja
Journal:  Dig Dis Sci       Date:  2014-12-09       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.